Beta

Onemednet corporationONMD.US Overview

US StockHealthcare
(No presentation for ONMD)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

ONMD AI Insights

ONMD Overall Performance

ONMD AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ONMD Recent Performance

2.75%

Onemednet corporation

-1.64%

Avg of Sector

-0.21%

S&P500

ONMD PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check ONMD's Trend

ONMD Key Information

ONMD Valuation Metrics

ONMD Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.

Price of ONMD

ONMD FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ONMD Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.09
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
42.25
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-38.38%
Net Margin
-205.96%
Revenue Growth (YoY)
111.51%
Profit Growth (YoY)
-85.77%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.09
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
42.25
PB Ratio
-
Price-to-FCF
-
Gross Margin
-38.38%
Net Margin
-205.96%
Revenue Growth (YoY)
111.51%
Profit Growth (YoY)
-85.77%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
  • When is ONMD's latest earnings report released?

    The most recent financial report for Onemednet corporation (ONMD) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ONMD's short-term business performance and financial health. For the latest updates on ONMD's earnings releases, visit this page regularly.

  • What is the operating profit of ONMD?

    According to the latest financial report, Onemednet corporation (ONMD) reported an Operating Profit of -3.08M with an Operating Margin of -345.9% this period, representing a decline of 15.6% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ONMD's revenue growth?

    In the latest financial report, Onemednet corporation (ONMD) announced revenue of 891K, with a Year-Over-Year growth rate of 3,326.92%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ONMD have?

    As of the end of the reporting period, Onemednet corporation (ONMD) had total debt of 974K, with a debt ratio of 0.45. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ONMD have?

    At the end of the period, Onemednet corporation (ONMD) held Total Cash and Cash Equivalents of 585K, accounting for 0.27 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ONMD go with three margins increasing?

    In the latest report, Onemednet corporation (ONMD) did not achieve the “three margins increasing” benchmark, with a gross margin of 18.5%%, operating margin of -345.9%%, and net margin of -352.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ONMD's profit trajectory and future growth potential.

  • Is ONMD's EPS continuing to grow?

    According to the past four quarterly reports, Onemednet corporation (ONMD)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.07. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ONMD?

    Onemednet corporation (ONMD)'s Free Cash Flow (FCF) for the period is -1.72M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 16.68% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ONMD?

    The latest valuation data shows Onemednet corporation (ONMD) has a Price-To-Earnings (PE) ratio of -14.8 and a Price/Earnings-To-Growth (PEG) ratio of -0.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.